Halozyme Therapeutics HALO Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's book value per share?
- Halozyme Therapeutics (HALO) reported book value per share of $1.79 in Q1 2026.
- How has Halozyme Therapeutics's book value per share changed year-over-year?
- Halozyme Therapeutics's book value per share decreased by 53.1% year-over-year, from $3.81 to $1.79.
- What is the long-term trend for Halozyme Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's book value per share has grown at a -17.7% compound annual growth rate (CAGR), from $1.04 to $0.39.
- What does book value per share mean?
- The accounting net worth of the company behind each share.
- How do you interpret book value per share?
- A steadily rising book value per share reflects retained earnings compounding into equity. Compare against the share price (price-to-book) to gauge how the market values that book equity.
- How does book value per share compare across companies?
- Most meaningful for asset- and equity-heavy businesses (financials, industrials); less informative for asset-light firms whose value is intangible.